Cancer Diagnostics

AACR applauds appointment of Anthony G. Letai, MD, PhD, as director of the National Cancer Institute

AI analysis of pathology results could result in new revenue streams for laboratories

New understanding of how mutations interact could pave way for early detection, prevention strategies

Insight into the strengths, limitations, and clinical utility of liquid biopsy for molecular profiling and residual disease detection

The Molecular EQA program ensures that biomarker testing meets the highest standards of accuracy and reliability, supporting proficiency testing as an important part of medical laboratory practice

Detecting cancers years before their clinical diagnosis could help provide management with a more favorable outcome

The FY2026 budget proposal includes devastating cuts to NIH of $18 billion, which would result in a nearly 40 percent cut in NIH’s budget for lifesaving research

As the frequency of late-stage cancer diagnoses rises, more accurate and efficient screening methods are needed to address overspending and improve early detection outcomes

The Today's Clinical Lab 2025 Cancer & Precision Medicine print issue features cancer screening successes, emerging technologies, and advances in targeted treatments

Large-scale functional studies are emerging that offer promise to improve variant interpretation